← Back to Patent Explorer
US4751071A Expired / Lapsed US ⏱️ 0.0 years remaining

Composition comprising salbutamol

Assignee: Alza Corp
•
Filing: 1987-01-07
•
Granted: 1988-06-14
•
Expires: 2007-01-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An osmotic delivery system is disclosed for delivering a useful agent at a controlled and constant rate modulated by a pulsed delivery of the useful agent to an environment of use.

Inventors

  • 👤 Paul R. Magruder
  • 👤 Brian Barclay
  • 👤 Patrick S. L. Wong
  • 👤 Felix Theeuwes

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 00:51
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0002; A61K9/0004; A61M; A61M31/00; A61M31/002

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 81 words
A composition for use in an osmotic device comprising: a beneficial agent comprising salbutamol, a modulating agent comprising sodium chloride which sodium chloride is present in an amount relative to the salbutamol less than the amount needed for the sodium chloride to maintain saturation in a fluid that enters the osmotic device, and wherein the composition when in said osmotic device is useful for dispensing salbutamol at a substantially zero order rate of delivery accompanied by a pulsed rate of delivery.
Claim 2
Dependent Claim 81 words
A composition for use in an osmotic device comprising: a beneficial agent comprising salbutamol, a modulating agent comprising sodium chloride which sodium chloride is present in an amount relative to the salbutamol less than the amount needed for the sodium chloride to maintain saturation in a fluid that enters the osmotic device, and wherein the composition when in said osmotic device is useful for dispensing salbutamol at a substantially zero order rate of delivery accompanied by a pulsed rate of delivery.

References Cited (Backward Citations)

US3644353A Cited
GB1453034A Cited
US4077407A Cited
US4111202A Cited
US4200098A Cited
US4285987A Cited
US4522625A Cited
US4539198A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-06-14 1991-12-14 1992-06-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-06-14 1995-12-14 1996-06-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-06-14 1999-12-14 2000-06-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag